Neochem Bio Solutions Annual General Meeting
Neochem Bio Solutions Limited held its 9th Annual General Meeting on September 21, 2026, where management reviewed the company's performance and discussed future business strategies.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements with these filters
Neochem Bio Solutions Limited held its 9th Annual General Meeting on September 21, 2026, where management reviewed the company's performance and discussed future business strategies.
Promoter Swapnil R. Makati acquired 1,200 equity shares of Neochem Bio Solutions Limited for ₹0.14 Crore via an on-market purchase.
Promoter and MD Swapnil Makati purchased 7,200 Neochem Bio Solutions shares on NSE for ₹0.07 Crore. His stake rose from 54.70% to 54.74%.
Neochem Bio Solutions Limited has appointed Mr. Siddharth Raj as Business Head (Textiles) Corporate Accounts. This Senior Management Personnel appointment is effective August 29, 2026.
Neochem Bio Solutions Limited has re-appointed M.K. Chokshi & Associates as Secretarial Auditor and Mrunal M. Shah & Co. as Internal Auditor for specified terms.
Neochem Bio Solutions Limited has scheduled its 9th Annual General Meeting for September 21, 2026, via video conferencing. The Board also approved the annual report.
Mr. Hitesh Wadher has resigned as Vice President - Marketing and Senior Management Personnel of Neochem Bio Solutions Limited, effective August 31, 2026.
Neochem Bio Solutions Limited has scheduled a board meeting for August 24, 2026, to discuss other business matters. No further details on the agenda were provided.
Promoter Swapnil Rameshbhai Makati purchased 7,200 shares of Neochem Bio Solutions for ₹0.06 Crore on the open market.
Promoter Swapnil R. Makati purchased 6,000 equity shares of Neochem Bio Solutions Limited for Rs. 5.14 Lakhs. This on-market acquisition increases his stake by 0.035%.
Neochem Bio Solutions has provided an update on its cyber fraud incident, reporting that ₹0.75 Crore has been successfully traced and frozen in beneficiary accounts.
Neochem Bio Solutions reported a cyber fraud incident involving unauthorized payments of ₹1.50 Crore. The company has initiated legal action and strengthened its payment protocols.
Neochem Bio Solutions reported FY26 revenue of ₹110.7 Cr (+32% YoY) and PAT of ₹12.0 Cr (+62% YoY), driven by specialty chemical demand and segment diversification into home and personal care.